Silvia Riondino

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 18

Top Topics

Machine Learning

Systematic Review

Metastatic Colorectal Cancer

Top Venues

Current oncology (Toronto, Ont.)

Journal of personalized medicine

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Silvia Riondino, Roberto Rosenfeld, Vincenzo Formica, Cristina Morelli, Giusy Parisi, Francesco Torino, Sabrina Mariotti, Mario Roselli
Effectiveness of Immunotherapy in Non-Small Cell Lung Cancer Patients with a Diagnosis of COPD: Is This a Hidden Prognosticator for Survival and a Risk Factor for Immune-Related Adverse Events? Cancers 16 (7) (2024)
Silvia Riondino, Roberto Rosenfeld, Vincenzo Formica, Cristina Morelli, Giusy Parisi, Francesco Torino, Sabrina Mariotti, Mario Roselli
Effectiveness of Immunotherapy in Non-Small Cell Lung Cancer Patients with a Diagnosis of COPD: Is This a Hidden Prognosticator for Survival and a Risk Factor for Immune-Related Adverse Events? Cancers 16 (7) (2024)
Silvia Riondino, Roberto Rosenfeld, Vincenzo Formica, Cristina Morelli, Giusy Parisi, Francesco Torino, Sabrina Mariotti, Mario Roselli
Effectiveness of Immunotherapy in Non-Small Cell Lung Cancer Patients with a Diagnosis of COPD: Is This a Hidden Prognosticator for Survival and a Risk Factor for Immune-Related Adverse Events? Cancers 16 (7) (2024)
Silvia Riondino, Vincenzo Formica, Elena Valenzi, Cristina Morelli, Valeria Flaminio, Ilaria Portarena, Francesco Torino, Mario Roselli
Obesity and Breast Cancer: Interaction or Interference with the Response to Therapy? Current oncology (Toronto, Ont.) 30 (1) (2023)
Stefano Sganga, Silvia Riondino, Giovanni Maria Iannantuono, Roberto Rosenfeld, Mario Roselli, Francesco Torino
Antibody-Drug Conjugates for the Treatment of Renal Cancer: A Scoping Review on Current Evidence and Clinical Perspectives. Journal of personalized medicine 13 (9) (2023)
Silvia Riondino, Vincenzo Formica, Elena Valenzi, Cristina Morelli, Valeria Flaminio, Ilaria Portarena, Francesco Torino, Mario Roselli
Obesity and Breast Cancer: Interaction or Interference with the Response to Therapy? Current oncology (Toronto, Ont.) 30 (1) (2023)
Silvia Riondino, Vincenzo Formica, Elena Valenzi, Cristina Morelli, Valeria Flaminio, Ilaria Portarena, Francesco Torino, Mario Roselli
Obesity and Breast Cancer: Interaction or Interference with the Response to Therapy? Current oncology (Toronto, Ont.) 30 (1) (2023)
Silvia Riondino, Vincenzo Formica, Elena Valenzi, Cristina Morelli, Valeria Flaminio, Ilaria Portarena, Francesco Torino, Mario Roselli
Obesity and Breast Cancer: Interaction or Interference with the Response to Therapy? Current oncology (Toronto, Ont.) 30 (1) (2023)
Silvia Riondino, Vincenzo Formica, Elena Valenzi, Cristina Morelli, Valeria Flaminio, Ilaria Portarena, Francesco Torino, Mario Roselli
Obesity and Breast Cancer: Interaction or Interference with the Response to Therapy? Current oncology (Toronto, Ont.) 30 (1) (2023)
Vincenzo Formica, Cristina Morelli, Veronica Conca, Maria Alessandra Calegari, Jessica Lucchetti, Emanuela Dell'Aquila, Marta Schirripa, Marco Messina, Lisa Salvatore, Federica Lo Prinzi, Giovanni Dima, Giovanni Trovato, Silvia Riondino, Mario Roselli, Ferdinandos Skoulidis, Hendrik-Tobias Arkenau, Chiara Cremolini
Irinotecan- vs. Oxaliplatin-Based Doublets in KRAS G12C -Mutated Metastatic Colorectal Cancer-A Multicentre Propensity-Score-Matched Retrospective Analysis. Cancers 15 (11) (2023)
Silvia Riondino, Vincenzo Formica, Elena Valenzi, Cristina Morelli, Valeria Flaminio, Ilaria Portarena, Francesco Torino, Mario Roselli
Obesity and Breast Cancer: Interaction or Interference with the Response to Therapy? Current oncology (Toronto, Ont.) 30 (1) (2023)
Valentina Russo, Eleonora Lallo, Armelle Munnia, Miriana Spedicato, Luca Messerini, Romina D'Aurizio, Elia Giuseppe Ceroni, Giulia Brunelli, Antonio Galvano, Antonio Russo, Ida Landini, Stefania Nobili, Marcello Ceppi, Marco Bruzzone, Fabio Cianchi, Fabio Staderini, Mario Roselli, Silvia Riondino, Patrizia Ferroni, Fiorella Guadagni, Enrico Mini, Marco Peluso
Artificial Intelligence Predictive Models of Response to Cytotoxic Chemotherapy Alone or Combined to Targeted Therapy for Metastatic Colorectal Cancer Patients: A Systematic Review and Meta-Analysis. Cancers 14 (16) (2022)
Giovanni Maria Iannantuono, Silvia Riondino, Stefano Sganga, Roberto Rosenfeld, Simona Guerriero, Manuela Carlucci, Barbara Capotondi, Francesco Torino, Mario Roselli
NTRK Gene Fusions in Solid Tumors and TRK Inhibitors: A Systematic Review of Case Reports and Case Series. Journal of personalized medicine 12 (11) (2022)
Giovanni Maria Iannantuono, Silvia Riondino, Stefano Sganga, Roberto Rosenfeld, Simona Guerriero, Manuela Carlucci, Barbara Capotondi, Francesco Torino, Mario Roselli
NTRK Gene Fusions in Solid Tumors and TRK Inhibitors: A Systematic Review of Case Reports and Case Series. Journal of personalized medicine 12 (11) (2022)
Giovanni Maria Iannantuono, Francesco Torino, Roberto Rosenfeld, Simona Guerriero, Manuela Carlucci, Stefano Sganga, Barbara Capotondi, Silvia Riondino, Mario Roselli
The Role of Histology-Agnostic Drugs in the Treatment of Metastatic Castration-Resistant Prostate Cancer. International journal of molecular sciences 23 (15) (2022)
Roberto Rosenfeld, Silvia Riondino, Vincenzo Formica, Francesco Torino, Eugenio Martuscelli, Mario Roselli
MiRNAs and circRNAs for the Diagnosis of Anthracycline-Induced Cardiotoxicity in Breast Cancer Patients: A Narrative Review. Journal of personalized medicine 12 (7) (2022)
Silvia Riondino, Patrizia Ferroni, Fabio Massimo Zanzotto, Mario Roselli, Fiorella Guadagni
Predicting VTE in Cancer Patients: Candidate Biomarkers and Risk Assessment Models. Cancers 11 (1) (2019)
Patrizia Ferroni, Fabio Massimo Zanzotto, Silvia Riondino, Noemi Scarpato, Fiorella Guadagni, Mario Roselli
Breast Cancer Prognosis Using a Machine Learning Approach. Cancers 11 (3) (2019)